163 related articles for article (PubMed ID: 6356516)
1. Clonal analysis of the lymphoid cells mediating skin allograft rejection. Mediation of graft rejection in vivo by cloned Lyt-1+2- proliferative, noncytotoxic long-term cell lines.
Kim B; Rosenstein M; Weiland D; Eberlein TJ; Rosenberg SA
Transplantation; 1983 Nov; 36(5):525-32. PubMed ID: 6356516
[TBL] [Abstract][Full Text] [Related]
2. In vitro growth of murine T cells. VI. Accelerated skin graft rejection caused by adoptively transferred cells expanded in T cell growth factor.
Rosenstein M; Eberlein T; Kemeny MM; Sugarbaker PH; Rosenberg SA
J Immunol; 1981 Aug; 127(2):566-71. PubMed ID: 7019327
[TBL] [Abstract][Full Text] [Related]
3. Cells mediating graft rejection in the mouse. I. Lyt-1 cells mediate skin graft rejection.
Loveland BE; Hogarth PM; Ceredig R; McKenzie IF
J Exp Med; 1981 May; 153(5):1044-57. PubMed ID: 7019377
[TBL] [Abstract][Full Text] [Related]
4. Different specificities of cloned T cells assessed by in vitro proliferation assays and by the ability to mediate skin graft rejection in vivo.
Lynch DH; Weiland DJ; Rosenberg SA; Hodes RJ
Transplantation; 1987 Mar; 43(3):408-11. PubMed ID: 3547797
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of antiskin allograft immunity induced by infusions with photoinactivated effector T lymphocytes (PET cells). Is in vivo cell transferrable?
Perez M; Lobo FM; Yamane Y; John L; Berger CL; Edelson RL
Ann N Y Acad Sci; 1991 Dec; 636():95-112. PubMed ID: 1793234
[TBL] [Abstract][Full Text] [Related]
6. A reexamination of the role of LYT-2-positive T cells in murine skin graft rejection.
LeFrancois L; Bevan MJ
J Exp Med; 1984 Jan; 159(1):57-67. PubMed ID: 6198428
[TBL] [Abstract][Full Text] [Related]
7. Phenotype, specificity, and function of T cell subsets and T cell interactions involved in skin allograft rejection.
Rosenberg AS; Mizuochi T; Sharrow SO; Singer A
J Exp Med; 1987 May; 165(5):1296-315. PubMed ID: 2437237
[TBL] [Abstract][Full Text] [Related]
8. Mediation of skin allograft rejection in scid mice by CD4+ and CD8+ T cells.
Shelton MW; Walp LA; Basler JT; Uchiyama K; Hanto DW
Transplantation; 1992 Aug; 54(2):278-86. PubMed ID: 1353912
[TBL] [Abstract][Full Text] [Related]
9. Rejection of skin grafts and generation of cytotoxic T cells by mice depleted of L3T4+ cells.
Woodcock J; Wofsy D; Eriksson E; Scott JH; Seaman WE
Transplantation; 1986 Dec; 42(6):636-42. PubMed ID: 2947360
[TBL] [Abstract][Full Text] [Related]
10. Heterogeneity of T cell clones specific for a single indirect alloantigenic epitope (I-Ab/H-2Kd54-68) that mediate transplant rejection.
Honjo K; Xu XY; Bucy RP
Transplantation; 2000 Nov; 70(10):1516-24. PubMed ID: 11118099
[TBL] [Abstract][Full Text] [Related]
11. T cell subsets in the immune rejection of murine heterotopic corneal allografts.
Matoba AY; Peeler JS; Niederkorn JY
Invest Ophthalmol Vis Sci; 1986 Aug; 27(8):1244-54. PubMed ID: 2942516
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of antiskin allograft immunity by infusions with syngeneic photoinactivated effector lymphocytes.
Perez M; Edelson R; Laroche L; Berger C
J Invest Dermatol; 1989 May; 92(5):669-76. PubMed ID: 2523941
[TBL] [Abstract][Full Text] [Related]
13. Alloantigen-specific CD4(+) regulatory T cells induced in vivo by ultraviolet irradiation after alloantigen immunization require interleukin-10 for their induction and activation, and flexibly mediate bystander immunosuppression of allograft rejection.
Hori T; Kuribayashi K; Saito K; Wang L; Torii M; Uemoto S; Kato T
Transpl Immunol; 2015 Jun; 32(3):156-63. PubMed ID: 25861842
[TBL] [Abstract][Full Text] [Related]
14. Simplified techniques for the isolation of alloreactive cell lines and clones with specific cytotoxic or proliferative activity.
Rosenstein M; Eberlein T; Schwarz S; Rosenberg SA
J Immunol Methods; 1983 Jul; 61(2):183-93. PubMed ID: 6602851
[TBL] [Abstract][Full Text] [Related]
15. Evolution of alloantibodies and suppressor cells in allografted mice treated for passive enhancement.
Duc HT; Kinsky RG; Monnot P; Voisin GA
Cell Immunol; 1985 Oct; 95(1):180-94. PubMed ID: 4028170
[TBL] [Abstract][Full Text] [Related]
16. Assessment of T cell function with a skin allograft assay.
Chang AE; Sugarbaker PH
Transplantation; 1980 May; 29(5):381-7. PubMed ID: 6990563
[TBL] [Abstract][Full Text] [Related]
17. Characterization of a cloned ultraviolet radiation (UV)-induced suppressor T cell line that is capable of inhibiting anti-UV tumor-immune responses.
Roberts LK
J Immunol; 1986 Mar; 136(5):1908-16. PubMed ID: 2936813
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of T cell-mediated cytolysis by monoclonal antibodies directed against Lyt-2: heterogeneity of inhibition at the clonal level.
MacDonald HR; Thiernesse N; Cerottini JC
J Immunol; 1981 May; 126(5):1671-5. PubMed ID: 6452474
[TBL] [Abstract][Full Text] [Related]
19. Generation of lytic and proliferative lymphoid clones to syngeneic tumor: in vitro and in vivo studies.
Rosenstein M; Rosenberg SA
J Natl Cancer Inst; 1984 May; 72(5):1161-5. PubMed ID: 6609266
[TBL] [Abstract][Full Text] [Related]
20. Donor-specific cellular immunity in rejecting and long-term-surviving class I-disparate rat renal allograft recipients.
Ruiz P; Fuller J; Sanfilippo F
Transplantation; 1990 Jan; 49(1):175-83. PubMed ID: 2301009
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
